This site is intended for healthcare professionals
FDA Hero  Banner - Multi-coloured pills and tablets
FDA Drug information

Methylene blue

Read time: 1 mins
Marketing start date: 28 Apr 2024

Summary of product characteristics


Effective Time

20231205

Version

1

Spl Product Data Elements

Methylene blue Methylene blue METHYLENE BLUE METHYLENE BLUE CATION TRISODIUM CITRATE DIHYDRATE ANHYDROUS CITRIC ACID WATER Methylene blue Methylene blue METHYLENE BLUE METHYLENE BLUE CATION TRISODIUM CITRATE DIHYDRATE ANHYDROUS CITRIC ACID WATER

Application Number

ANDA215636

Brand Name

Methylene blue

Generic Name

Methylene blue

Product Ndc

70771-1768

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAVENOUS

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1768-1 Methylene Blue Injection, USP 50 mg/10 mL (5 mg/mL) Intravenous use only Single-Dose vial Rx only NDC 70771-1768-5 Methylene Blue Injection, USP 50 mg/10 mL (5 mg/mL) Intravenous use only For slow intravenous injection Use 5% Dextrose Injection When Diluting Discard unused portion 5 X 10 mL Single-Dose vial Rx only NDC 70771-1767-1 Methylene Blue Injection, USP 10 mg/2 mL (5 mg/mL) Intravenous use only Single-Dose vial Rx only 50 mg per 10 mL vial 50 mg per 10 mL carton 10 mg per 2 mL carton

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.